In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payload

被引：7
|
作者：
Lai, Katharine C.
Muvaffak, Asli
Li, Min
Themeles, Marian
Sikka, Surina
Donahue, Kerry
Hicks, Stuart W.
Romanelli, Angela
Chittenden, Thomas
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Zhu, Xiao-yi
    Li, Quan-xiao
    Kong, Yu
    Huang, Ke-ke
    Wang, Gang
    Wang, Yun-ji
    Lu, Jun
    Hua, Guo-qiang
    Wu, Yan-ling
    Ying, Tian-lei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (03) : 609 - 618
  • [22] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Xiao-yi Zhu
    Quan-xiao Li
    Yu Kong
    Ke-ke Huang
    Gang Wang
    Yun-ji Wang
    Jun Lu
    Guo-qiang Hua
    Yan-ling Wu
    Tian-lei Ying
    Acta Pharmacologica Sinica, 2024, 45 : 609 - 618
  • [23] Phase I dose-escalation trial with the DNA-alkylating anti-HER2 antibody-drug conjugate SYD985
    Van Herpen, C. M.
    Banerji, U.
    Mommers, E. C.
    Koper, N. P.
    Goedings, P.
    Lopez, J.
    Awada, A.
    Fiebrich, H. B.
    Aftimos, P. G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S65 - S65
  • [24] A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo
    Dal Corso, Alberto
    Gebleux, Remy
    Murer, Patrizia
    Soltermann, Alex
    Neri, Dario
    JOURNAL OF CONTROLLED RELEASE, 2017, 264 : 211 - 218
  • [25] A novel c-Met/EGFR bispecific targeting antibody drug conjugate for NSCLC
    Chen, Gang
    Li, Lingna
    Muyot, Pia
    Gros, Edwige
    Zhang, Yanliang
    Sun, Yingqing
    Zhang, Hong
    Fu, Yanwen
    Lee, Alice
    Cao, Jian
    Kaufmann, Gunnar
    Miao, Zhenwei
    CANCER RESEARCH, 2015, 75
  • [26] Determination of Antibody-Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric Interrogation
    Bessire, Andrew J.
    Ballard, T. Eric
    Charati, Manoj
    Cohen, Justin
    Green, Michael
    Lam, My-Hanh
    Loganzo, Frank
    Nolting, Birte
    Pierce, Betsy
    Puthenveetil, Sujiet
    Roberts, Lee
    Schildknegt, Klaas
    Subramanyam, Chakrapani
    BIOCONJUGATE CHEMISTRY, 2016, 27 (07) : 1645 - 1654
  • [27] Phase 1b study evaluating the efficacy and safety of ABBV-400, a c-Met-targeting antibody-drug conjugate, in select advanced solid tumor indications.
    Perets, Ruth
    Sharma, Manish
    Strickler, John H.
    Golan, Talia
    Hollebecque, Antoine
    Henner, William
    Vasilopoulos, Athanasios
    Thiele, Gladys Morrison
    Burns, Michael Charles
    Harding, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate
    Kaeding, Allison
    Tarlock, Katherine
    Kolb, E. Anders
    Meshinchi, Soheil
    BLOOD, 2018, 132
  • [29] In vitro characterization of a novel TROP2-targeting antibody-drug conjugate OBI992
    Kuo, Tzer-Min
    Chang, Ting-Yu
    Huang, Jye-Yu
    Tang, Wei-Chien
    Lin, Chun-Jung
    Wu, Yi-Chen
    Lu, Chi-Huan
    Weng, Hao-Cheng
    Chen, Yu-Jung
    Tsao, Yu-Hsuan
    Wei, Cheng-Yen
    Shen, Lifen
    Li, Wan-Fen
    Lai, Ming-Tain
    CANCER RESEARCH, 2024, 84 (06)
  • [30] In vitro and in vivo targeting and therapy of an antibody-drug conjugate (IMMU-110) in B-cell malignancies
    Sapra, P
    Stein, R
    Pickett, J
    Govindan, SV
    Cardillo, TM
    Damoci, C
    Sheerin, A
    Hansen, HJ
    Horak, ID
    Griffiths, GL
    Goldenberg, DM
    BLOOD, 2004, 104 (11) : 898A - 898A
12345